Grubmüller, B.; Huebner, N.A.; Rasul, S.; Clauser, P.; Pötsch, N.; Grubmüller, K.H.; Hacker, M.; Hartenbach, S.; Shariat, S.F.; Hartenbach, M.;
et al. Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer. Curr. Oncol. 2023, 30, 1683-1691.
https://doi.org/10.3390/curroncol30020129
AMA Style
Grubmüller B, Huebner NA, Rasul S, Clauser P, Pötsch N, Grubmüller KH, Hacker M, Hartenbach S, Shariat SF, Hartenbach M,
et al. Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer. Current Oncology. 2023; 30(2):1683-1691.
https://doi.org/10.3390/curroncol30020129
Chicago/Turabian Style
Grubmüller, Bernhard, Nicolai A. Huebner, Sazan Rasul, Paola Clauser, Nina Pötsch, Karl Hermann Grubmüller, Marcus Hacker, Sabrina Hartenbach, Shahrokh F. Shariat, Markus Hartenbach,
and et al. 2023. "Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer" Current Oncology 30, no. 2: 1683-1691.
https://doi.org/10.3390/curroncol30020129
APA Style
Grubmüller, B., Huebner, N. A., Rasul, S., Clauser, P., Pötsch, N., Grubmüller, K. H., Hacker, M., Hartenbach, S., Shariat, S. F., Hartenbach, M., & Baltzer, P.
(2023). Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer. Current Oncology, 30(2), 1683-1691.
https://doi.org/10.3390/curroncol30020129
